In the News
Pacific Biosciences announced that Suqian Lakeside Pangu Gene Company (SLPC) established a new 1,500 square meter genomics facility in Tianjin, China dedicated to using PacBio Single Molecule, Real Time (SMRT®) Sequencing as the major sequencing platform for its translational medicine research projects.
Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced the release of new chemistry and software designed to enhance read length and accuracy for the study of human and other complex genomes.
Production of Cornell’s newest apple varieties is ramping up with SnapDragon coming to market in limited quantities this November and RubyFrost becoming available through several retailers in January 2015.
Hurel, a provider of in vitro liver models that bring improved translational utility to pre-clinical drug development, and ACEA Biosciences, provider of impedance-based, label-free, real-time cell analysis instrumentation, announced that they will begin to offer their respective technologies combined together in a single, integrated cell-based assay platform with a launch planned for the first quarter of 2015.
Armory Square Ventures, a new venture fund, has closed its first investment as part of a $2.2 million round of financing for Agronomic Technology Corp.
Researchers at Weill Cornell Medical College have developed technologies that allow investigators to watch HIV proteins on the virus’ surface, which may contribute to how it infects human immune cells.
Human Longevity, Inc. has added Pacific Bioscience’s Single Molecule, Real-Time (SMRT®) Sequencing technology to their repertoire of DNA sequencing technologies to compile a comprehensive human genotype, microbiome, and phenotype database.
Life Extension announced the launch of NAD+ Cell Regenerator™, a nutritional supplement that boosts vitality and supports healthy aging, featuring the ingredient NIAGEN™ from ChromaDex, a natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. NIAGEN™ is the commercially available brand of Nicotinamide Riboside (NR), developed at Cornell.
For archived news items, click here.